• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

源自对假定的β-氨基酰胺类配体分子内氢键模式的作用和影响提出质疑的新型 M 阳性变构调节剂。

Novel M positive allosteric modulators derived from questioning the role and impact of a presumed intramolecular hydrogen-bonding motif in β-amino carboxamide-harboring ligands.

机构信息

Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, School of Medicine, Nashville, TN 37232, USA; Department of Pharmacology, Vanderbilt University, School of Medicine, Nashville, TN 37232, USA.

Vanderbilt Center for Neuroscience Drug Discovery, Vanderbilt University, School of Medicine, Nashville, TN 37232, USA; Department of Pharmacology, Vanderbilt University, School of Medicine, Nashville, TN 37232, USA; Vanderbilt Kennedy Center, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.

出版信息

Bioorg Med Chem Lett. 2019 Feb 1;29(3):362-366. doi: 10.1016/j.bmcl.2018.12.039. Epub 2018 Dec 18.

DOI:10.1016/j.bmcl.2018.12.039
PMID:30580918
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6690489/
Abstract

This letter describes a focused exercise to explore the role of the β-amino carboxamide moiety found in all of the first generation M PAMs and question if the NH group served solely to stabilize an intramolecular hydrogen bond (IMHB) and enforce planarity. To address this issue (and to potentially find a substitute for the β-amino carboxamide that engendered P-gp and contributed to solubility liabilities), we removed the NH, generating des-amino congeners and surveyed other functional groups in the β-position. These modifications led to weak M PAMs with poor DMPK properties. Cyclization of the β-amino carboxamide moiety by virtue of a pyrazole ring re-enforced the IMHB, led to potent (and patented) M PAMs, many as potent as the classical bicyclic β-amino carboxamide analogs, but with significant CYP1A2 inhibition. Overall, this exercise indicated that the β-amino carboxamide moiety most likely facilitates an IMHB, and is essential for M PAM activity within classical bicyclic M PAM scaffolds.

摘要

这封信描述了一项集中探讨的工作,旨在探索第一代 M PAMs 中所有存在的β-氨基甲酰胺部分的作用,并质疑 NH 基团是否仅用于稳定分子内氢键(IMHB)并强制平面性。为了解决这个问题(并可能找到取代β-氨基甲酰胺的方法,该取代物会引起 P-糖蛋白并导致溶解度问题),我们去除了 NH,生成了去氨基同系物,并在β-位上调查了其他官能团。这些修饰导致了弱的 M PAMs,具有较差的 DMPK 性质。通过吡唑环使β-氨基甲酰胺部分环化,重新增强了 IMHB,导致了有效的(并已获得专利)M PAMs,许多与经典的双环β-氨基甲酰胺类似物一样有效,但对 CYP1A2 有明显抑制作用。总体而言,这项工作表明β-氨基甲酰胺部分很可能有助于形成 IMHB,并且对于经典双环 M PAM 支架内的 M PAM 活性是必不可少的。

相似文献

1
Novel M positive allosteric modulators derived from questioning the role and impact of a presumed intramolecular hydrogen-bonding motif in β-amino carboxamide-harboring ligands.源自对假定的β-氨基酰胺类配体分子内氢键模式的作用和影响提出质疑的新型 M 阳性变构调节剂。
Bioorg Med Chem Lett. 2019 Feb 1;29(3):362-366. doi: 10.1016/j.bmcl.2018.12.039. Epub 2018 Dec 18.
2
Discovery of a novel 2,4-dimethylquinoline-6-carboxamide M positive allosteric modulator (PAM) chemotype via scaffold hopping.通过骨架跃迁发现一种新型2,4-二甲基喹啉-6-甲酰胺M正变构调节剂(PAM)化学类型。
Bioorg Med Chem Lett. 2017 Nov 15;27(22):4999-5001. doi: 10.1016/j.bmcl.2017.10.016. Epub 2017 Oct 9.
3
Challenges in the development of an M PAM preclinical candidate: The discovery, SAR, and in vivo characterization of a series of 3-aminoazetidine-derived amides.MPAM临床前候选药物开发中的挑战:一系列3-氨基氮杂环丁烷衍生酰胺的发现、构效关系及体内特性研究
Bioorg Med Chem Lett. 2017 Jul 1;27(13):2990-2995. doi: 10.1016/j.bmcl.2017.05.014. Epub 2017 May 6.
4
VU6005806/AZN-00016130, an advanced M positive allosteric modulator (PAM) profiled as a potential preclinical development candidate.VU6005806/AZN - 00016130,一种先进的M阳性变构调节剂(PAM),被评估为潜在的临床前开发候选药物。
Bioorg Med Chem Lett. 2019 Jul 15;29(14):1714-1718. doi: 10.1016/j.bmcl.2019.05.026. Epub 2019 May 16.
5
Discovery of a novel 2,3-dimethylimidazo[1,2-a]pyrazine-6-carboxamide M positive allosteric modulator (PAM) chemotype.发现一种新型 2,3-二甲基咪唑并[1,2-a]吡嗪-6-甲酰胺 M 正变构调节剂(PAM)化学型。
Bioorg Med Chem Lett. 2020 Feb 1;30(3):126812. doi: 10.1016/j.bmcl.2019.126812. Epub 2019 Nov 13.
6
Discovery of structurally distinct tricyclic M positive allosteric modulator (PAM) chemotypes - Part 2.结构独特的三环 M 型正变构调节剂(PAM)化学型的发现 - 第 2 部分。
Bioorg Med Chem Lett. 2021 Dec 1;53:128416. doi: 10.1016/j.bmcl.2021.128416. Epub 2021 Oct 26.
7
Challenges in the development of an M PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amides.MPAM临床前候选药物开发中的挑战:一系列氮杂环丁烷衍生的叔酰胺的发现、构效关系及生物学特性
Bioorg Med Chem Lett. 2017 Dec 1;27(23):5179-5184. doi: 10.1016/j.bmcl.2017.10.053. Epub 2017 Oct 24.
8
Discovery of a novel 3,4-dimethylcinnoline carboxamide M positive allosteric modulator (PAM) chemotype via scaffold hopping.通过骨架跃迁发现一种新型3,4-二甲基喹喔啉甲酰胺M正变构调节剂(PAM)化学类型。
Bioorg Med Chem Lett. 2019 Nov 1;29(21):126678. doi: 10.1016/j.bmcl.2019.126678. Epub 2019 Sep 10.
9
Challenges in the development of an M PAM in vivo tool compound: The discovery of VU0467154 and unexpected DMPK profiles of close analogs.开发一种体内 M PAM 工具化合物的挑战:VU0467154 的发现及紧密类似物意外的药物代谢动力学特征。
Bioorg Med Chem Lett. 2017 Jan 15;27(2):171-175. doi: 10.1016/j.bmcl.2016.11.086. Epub 2016 Nov 30.
10
Discovery of a novel, CNS penetrant M PAM chemotype based on a 6-fluoro-4-(piperidin-1-yl)quinoline-3-carbonitrile core.基于6-氟-4-(哌啶-1-基)喹啉-3-腈核心发现一种新型的可穿透中枢神经系统的M PAM化学类型。
Bioorg Med Chem Lett. 2017 Sep 15;27(18):4274-4279. doi: 10.1016/j.bmcl.2017.08.043. Epub 2017 Aug 20.

引用本文的文献

1
Fine Tuning Muscarinic Acetylcholine Receptor Signaling Through Allostery and Bias.通过变构和偏向性微调毒蕈碱型乙酰胆碱受体信号传导
Front Pharmacol. 2021 Jan 29;11:606656. doi: 10.3389/fphar.2020.606656. eCollection 2020.
2
Exception That Proves the Rule: Investigation of Privileged Stereochemistry in Designing Dopamine DR Bitopic Agonists.反例证明规则:多巴胺DR双位点激动剂设计中优势立体化学的研究
ACS Med Chem Lett. 2020 Feb 28;11(10):1956-1964. doi: 10.1021/acsmedchemlett.9b00660. eCollection 2020 Oct 8.
3
SAR inspired by aldehyde oxidase (AO) metabolism: Discovery of novel, CNS penetrant tricyclic M PAMs.

本文引用的文献

1
Cholinergic Projections to the Substantia Nigra Pars Reticulata Inhibit Dopamine Modulation of Basal Ganglia through the M Muscarinic Receptor.胆碱能投射到黑质网状部抑制多巴胺通过 M 型毒蕈碱受体调制基底神经节。
Neuron. 2017 Dec 20;96(6):1358-1372.e4. doi: 10.1016/j.neuron.2017.12.008.
2
Challenges in the development of an M PAM preclinical candidate: The discovery, SAR, and biological characterization of a series of azetidine-derived tertiary amides.MPAM临床前候选药物开发中的挑战:一系列氮杂环丁烷衍生的叔酰胺的发现、构效关系及生物学特性
Bioorg Med Chem Lett. 2017 Dec 1;27(23):5179-5184. doi: 10.1016/j.bmcl.2017.10.053. Epub 2017 Oct 24.
3
基于醛氧化酶(AO)代谢的 SAR 研究:新型中枢神经系统穿透性三环 M PAMs 的发现。
Bioorg Med Chem Lett. 2019 Aug 15;29(16):2224-2228. doi: 10.1016/j.bmcl.2019.06.032. Epub 2019 Jun 20.
Discovery of a novel 2,4-dimethylquinoline-6-carboxamide M positive allosteric modulator (PAM) chemotype via scaffold hopping.
通过骨架跃迁发现一种新型2,4-二甲基喹啉-6-甲酰胺M正变构调节剂(PAM)化学类型。
Bioorg Med Chem Lett. 2017 Nov 15;27(22):4999-5001. doi: 10.1016/j.bmcl.2017.10.016. Epub 2017 Oct 9.
4
Discovery of a novel, CNS penetrant M PAM chemotype based on a 6-fluoro-4-(piperidin-1-yl)quinoline-3-carbonitrile core.基于6-氟-4-(哌啶-1-基)喹啉-3-腈核心发现一种新型的可穿透中枢神经系统的M PAM化学类型。
Bioorg Med Chem Lett. 2017 Sep 15;27(18):4274-4279. doi: 10.1016/j.bmcl.2017.08.043. Epub 2017 Aug 20.
5
Cognitive enhancement and antipsychotic-like activity following repeated dosing with the selective M PAM VU0467154.反复给予选择性 M PAM VU0467154 后认知增强和类抗精神病活性。
Neuropharmacology. 2018 Jan;128:492-502. doi: 10.1016/j.neuropharm.2017.07.013. Epub 2017 Jul 17.
6
Challenges in the development of an M PAM preclinical candidate: The discovery, SAR, and in vivo characterization of a series of 3-aminoazetidine-derived amides.MPAM临床前候选药物开发中的挑战:一系列3-氨基氮杂环丁烷衍生酰胺的发现、构效关系及体内特性研究
Bioorg Med Chem Lett. 2017 Jul 1;27(13):2990-2995. doi: 10.1016/j.bmcl.2017.05.014. Epub 2017 May 6.
7
Optimization of M positive allosteric modulators (PAMs): The discovery of VU0476406, a non-human primate in vivo tool compound for translational pharmacology.M 阳性变构调节剂(PAMs)的优化:VU0476406 的发现,一种用于转化药理学的非人灵长类动物体内工具化合物。
Bioorg Med Chem Lett. 2017 Jun 1;27(11):2296-2301. doi: 10.1016/j.bmcl.2017.04.043. Epub 2017 Apr 13.
8
Discovery of VU0467485/AZ13713945: An M PAM Evaluated as a Preclinical Candidate for the Treatment of Schizophrenia.VU0467485/AZ13713945的发现:一种被评估为治疗精神分裂症临床前候选药物的代谢型谷氨酸受体正向变构调节剂
ACS Med Chem Lett. 2016 Dec 16;8(2):233-238. doi: 10.1021/acsmedchemlett.6b00461. eCollection 2017 Feb 9.
9
Challenges in the development of an M PAM in vivo tool compound: The discovery of VU0467154 and unexpected DMPK profiles of close analogs.开发一种体内 M PAM 工具化合物的挑战:VU0467154 的发现及紧密类似物意外的药物代谢动力学特征。
Bioorg Med Chem Lett. 2017 Jan 15;27(2):171-175. doi: 10.1016/j.bmcl.2016.11.086. Epub 2016 Nov 30.
10
Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release.M4 正变构调节剂的抗精神病样作用由 CB2 受体依赖性抑制多巴胺释放介导。
Neuron. 2016 Sep 21;91(6):1244-1252. doi: 10.1016/j.neuron.2016.08.017. Epub 2016 Sep 8.